Clinical Overview
Oxcarbazepine is an anticonvulsant indicated for the treatment of partial-onset seizures as monotherapy or adjunctive therapy in adults and children. It is structurally related to carbamazepine but offers improved tolerability and fewer drug interactions, making it a preferred alternative for many patients.
Primary Clinical Applications
Oxcarbazepine is indicated for partial-onset seizures in adults and children 2 years and older. It is also used off-label for bipolar disorder, trigeminal neuralgia, and neuropathic pain conditions, offering similar efficacy to carbamazepine with better tolerability.
Mechanism and Clinical Benefits
Oxcarbazepine blocks voltage-sensitive sodium channels, stabilizing hyperexcited neural membranes and preventing repetitive neuronal firing. Unlike carbamazepine, it does not induce its own metabolism and has fewer drug interactions through cytochrome P450 systems.
Safety Profile
The medication has a more favorable side effect profile than carbamazepine, with lower risk of serious hematologic effects and fewer drug interactions. However, it requires monitoring for hyponatremia and skin reactions.
Prescribing Information
Dosing & Administration
Partial-Onset Seizures – Adults:
- Monotherapy initial: 600 mg daily in 2 divided doses
- Monotherapy target: 1200 mg daily
- Adjunctive initial: 600 mg daily in 2 divided doses
- Adjunctive target: 1200 mg daily
- Maximum: 2400 mg daily
Pediatric (2-16 years):
- Initial: 8-10 mg/kg/day in 2 divided doses
- Target: 900 mg daily (20-29 kg), 1200 mg daily (29.1-39 kg)
- Maximum: 1800 mg daily (>39 kg)
Renal Impairment:
- CrCl <30 mL/min: Reduce initial dose by 50%
Indications
- Partial-onset seizures (monotherapy or adjunctive)
- Off-label: Bipolar disorder, trigeminal neuralgia, neuropathic pain
Contraindications
- Known hypersensitivity to oxcarbazepine or any component
Warnings & Precautions
- Hyponatremia: Monitor serum sodium, especially in elderly
- Serious skin reactions: Stevens-Johnson syndrome, TEN
- Cross-hypersensitivity: 25-30% with carbamazepine
- Suicidal thoughts: Monitor for behavioral changes
- Withdrawal seizures: Taper gradually when discontinuing
Drug Interactions
- Oral contraceptives: Decreased effectiveness
- Carbamazepine: Decreased oxcarbazepine levels
- Phenytoin: Increased phenytoin levels
- Warfarin: Monitor INR
- Calcium channel blockers: Decreased levels
Adverse Reactions
Common (≥10%):
- Dizziness, somnolence, diplopia, fatigue, nausea
Serious:
- Hyponatremia, serious skin reactions, multi-organ hypersensitivity
Special Populations
- Pregnancy: Category C – use if benefits outweigh risks
- Renal Impairment: Dose reduction required for severe impairment
- Elderly: Increased risk of hyponatremia
- Asian ancestry: Screen for HLA-B*1502 allele
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.
